Our mission is to help people see more clearly and improve their quality of life.

Our technology is clinically proven to improve vision across a variety of vision conditions and is FDA-cleared for amblyopia over age 9. RevitalVision enhances the brain's visual processing, enabling significant vision improvements beyond standard eye care, truly making a difference

Meet the Team

Yair Yahav

Founder & CEO

Yogev Shamay

Co-founder & CTO

Yuval Ron-Ruhama

COO

Charles Morris

General Manager –N. America

Yonina Thee

Clinical Specialist

Inbal Sasson

Clinical Research Manager

Shlomo Abramson

Clinical Service Manager

Rona Erlich

Marketing Director

Board

Yariv Baron

Director

Dr. Shulamit Hadi

Director

Alon Reshef

Director & Shareholder

Simon Kan

Director

Advisory Board

Amir Belson, M.D.

Advisory Board

Prof. Richard W. Hertle (MD)

Scientific & Clinical Advisor

Prof. Ramesh
 Kekunnaya (MD)

Scientific & Clinical Advisor

Dr. Sarah Maling (MD)

Advisory Board

Mike Turner

Advisory Board

Prof. Yair Morad (MD)

Scientific & Clinical Advisor

Latest News and Events

April 2025

RevitalVision Wins Three First Place Awards at ASCRS 2025

An incredible milestone for RevitalVision at ASCRS 2025

We are proud to announce that two RevitalVision clinical studies were awarded First Place at the prestigious ASCRS Annual Meeting in Los Angeles — a true testament to the strength of our clinical evidence and the impact of our technology in advancing vision care.

Dr. Lional Raj Daniel, for receiving two First Place awards:

– One for his presentation on cortical stimulation improving vision and contrast sensitivity in keratoconus patients using RevitalVision’s technology.

– Another for his study, “Cortical Stimulation Using Gabor Patches Improves Vision and Contrast Sensitivity in Dissatisfied Patients with MF-IOLs” — a randomized controlled trial showing promising results.

Dr. @Adi Einan-Lifshitz, for her exceptional presentation, “Visual Perceptual Learning Improves Visual Acuity in Stable Keratoconus Patients – Preliminary Results of a Randomized Controlled Study,” showcasing impressive clinical outcomes.

March 2025

Dr. Jordan Dau on “The Power Hour” podcast

In this Power Hour episode with Eugene Shatsman, Dr. Jordan Dau shares his journey in transforming his practice into a technology-driven, specialty-focused clinic. He discusses how integrating cutting-edge innovations like RevitalVision’s Brain Training Technology can open new revenue opportunities for optometrists.

Watch the full episode

March 2025

New publihsed study: Long-term efficacy of perceptual learning therapy in amblyopia: A 5-year follow-up study

This new study was just published in the Latin American Journal of Ophthalmology (LAJO) and is the first study to evaluate the long-term effect of RevitalVision on adult patients with amblyopia.

Read article

February 25

RevitalVision makes US debut with digital vision enhancement technology

Eyes On Eyecare magazine has featured RevitalVision’s U.S. debut!

Read more about our journey to innovate vision care.

Read article

December 24

RevitalVision featured on Healio – Improving vision in Keratoconus patients

The article highlights a recent study published in the American Journal of Ophthalmology, showcasing significant vision improvements in keratoconus patients using RevitalVision’s technology.
The study demonstrates how RevitalVision’s targeted vision training improves functional vision with a long-lasting effect in keratoconus patients who are intolerant to contact lenses and do not achieve good vision with spectacles.

Read the full article

November 24

New published study in the American Journal of Ophthalmology- improving vision in Keratoconus

We are proud to share a recently published independent randomized controlled study demonstrating RevitalVision’s efficacy in improving vision in patients with keratoconus. The study was published in the American Journal of Ophthalmology – September 2024

Read article

1 2 3 … 7 »